Need Help? +91 95 998 41663
Global package for total price over 8000
2019年10月21日 阿斯利康宣布美国FDA(食品药品监督管理局)批准安达唐(达格列净) Farxiga(Dapagliflozin)用于治疗因2型糖尿病(T2D),已确诊的心血管疾病(CVD)或多发性心脏病引起的心力衰竭(hHF)。
We make consolidating, marketing and tracking your social media website easy.
You can try to enter the keywords you are interested in to search for the information you need.
India Bosheng Pharmacy app is under production with two ends.